Imatinib mesylate-induced interstitial pneumonitis

被引:31
作者
Ma, CX [1 ]
Hobday, TJ [1 ]
Jett, JR [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
D O I
10.4065/78.12.1578
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1578 / 1579
页数:2
相关论文
共 4 条
[1]   Hypersensitivity pneumonitis related to imatinib mesylate [J].
Bergeron, A ;
Bergot, E ;
Vilela, G ;
Ades, L ;
Devergie, A ;
Espérou, H ;
Socié, G ;
Calvo, F ;
Gluckman, E ;
Ribaud, P ;
Rousselot, P ;
Tazi, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4271-4272
[2]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[3]   Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].
Kantarjian, H ;
Sawyers, C ;
Hochhaus, A ;
Guilhot, F ;
Schiffer, C ;
Gambacorti-Passerini, C ;
Niederwieser, D ;
Resta, D ;
Capdeville, R ;
Zoellner, U ;
Talpaz, M ;
Druker, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652
[4]   Challenging problems in advanced malignancy - Case 3. Imatinib mesylate-induced interstitial pneumonitis [J].
Rosado, MF ;
Donna, E ;
Ahn, YS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3171-3173